Lexicon Pharmaceuticals, Inc. (LXRX)

Lexicon Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for LXRX stock has a target of 8.00, which predicts an increase of 384.85% from the current stock price of 1.65.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$8.00	$8.00	$8.00
Change	+384.85%	+384.85%	+384.85%	+384.85%

* Price targets were last updated on May 31, 2023.

Analyst Ratings

The average analyst rating for LXRX stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '23	Dec '23	Jan '24	Feb '24	Mar '24	Apr '24
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	1	0
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Stringer Needham	Needham	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 11, 2024
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $6 → $8	Strong Buy	Maintains	$6 → $8	+384.85%	May 31, 2023
Joseph Stringer Needham	Needham	Hold Maintains n/a	Hold	Maintains	n/a	n/a	May 30, 2023
Andrew Tsai Jefferies	Jefferies	Hold Initiates $3	Hold	Initiates	$3	+81.82%	Mar 7, 2023
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $16 → $6	Strong Buy	Maintains	$16 → $6	+263.64%	Nov 22, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

26.33M

Increased by 2,086.71%

from 1.20M

Revenue Next Year

70.68M

Increased by 168.47%

from 26.33M

EPS This Year

-0.72

from -0.80

EPS Next Year

-0.67

from -0.72

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	322.07M	24.00M	298.00K	139.00K	1.20M	26.33M	70.68M	173.88M	356.56M	711.25M
Revenue Growth	409.54%	-92.55%	-98.76%	-53.36%	766.19%	2,086.71%	168.47%	146.00%	105.06%	99.48%
EPS	1.16	-0.53	-0.60	-0.62	-0.80	-0.72	-0.67	-0.37	0.86	1.29
EPS Growth	-	-	-	-	-	-	-	-	-	50.00%
No. Analysts	-	-	-	-	-	6	6	4	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	42.1M	108.2M	248.0M	571.6M	732.2M
Avg	26.3M	70.7M	173.9M	356.6M	711.3M
Low	10.6M	39.3M	102.6M	151.7M	683.4M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	3,400.2%	311.1%	250.9%	228.7%	105.3%
Avg	2,086.7%	168.5%	146.0%	105.1%	99.5%
Low	779.1%	49.3%	45.2%	-12.8%	91.7%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-0.70	-0.65	-0.13	0.88	1.32
Avg	-0.72	-0.67	-0.37	0.86	1.29
Low	-0.74	-0.68	-0.60	0.82	1.23

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-	-	54.4%
Avg	-	-	-	-	50.0%
Low	-	-	-	-	44.1%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.